Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
Identifieur interne : 001A24 ( Main/Exploration ); précédent : 001A23; suivant : 001A25Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
Auteurs : Tamar Ben-Yedidia [Israël] ; Hadar Marcus [Israël] ; Yair Reisner [Israël] ; Ruth Arnon [Israël]Source :
- International Immunology [ 0953-8178 ] ; 1999.
Abstract
Influenza virus is characterized by frequent and unpredictable changes of the surface glycoproteins which enable the virus to escape the immune system. Approved vaccines which consist of the whole virus or the surface glycoproteins fail to induce broad specificity protection. We have previously reported that a peptide-based experimental recombinant vaccine which includes conserved epitopes of B and T lymphocytes was efficient in mice, leading to cross-strain, long-term protection. In the present study, this approach was adapted for the design of a human vaccine, based on epitopes recognized by the prevalent HLAs. These epitopes were expressed in Salmonella flagellin and tested for their efficacy in human/mouse radiation chimera in which human peripheral blood mononuclear cells (PBMC) are functionally engrafted. The vaccinated mice demonstrated clearance of the virus after challenge and resistance to lethal infection. The production of virus-specific human antibodies was also higher in this group. Control groups of either non-vaccinated, or vaccinated mice which had not been engrafted with the human PBMC, did not exhibit the protective immune response. FACS analysis showed that most human cells in the transplanted mice are CD8+ and CD4+. Hence, it may be concluded: (i) that the protection involves cellular mechanisms, but is most probably accomplished without direct lysis of influenza-infected pulmonary cells by cytotoxic T lymphocytes, but rather via a cytokine-mediated mechanism, (ii) that the human/mouse radiation chimera model may be of some value in the investigation of new vaccines, as an additional tool prior to clinical trials, and (iii) that the synthetic recombinant vaccine can induce a response in the human immune system and confers protection against influenza infection. Further investigation is needed to establish the efficacy of such a peptide vaccine in human subjects.
Url:
DOI: 10.1093/intimm/11.7.1043
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000950
- to stream Istex, to step Curation: 000950
- to stream Istex, to step Checkpoint: 000824
- to stream Main, to step Merge: 001A71
- to stream Main, to step Curation: 001A24
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection</title><author><name sortKey="Ben Yedidia, Tamar" sort="Ben Yedidia, Tamar" uniqKey="Ben Yedidia T" first="Tamar" last="Ben-Yedidia">Tamar Ben-Yedidia</name></author><author><name sortKey="Marcus, Hadar" sort="Marcus, Hadar" uniqKey="Marcus H" first="Hadar" last="Marcus">Hadar Marcus</name></author><author><name sortKey="Reisner, Yair" sort="Reisner, Yair" uniqKey="Reisner Y" first="Yair" last="Reisner">Yair Reisner</name></author><author><name sortKey="Arnon, Ruth" sort="Arnon, Ruth" uniqKey="Arnon R" first="Ruth" last="Arnon">Ruth Arnon</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:61B2B4253296591CDF5453B79ABFB1264A5E5939</idno><date when="1999" year="1999">1999</date><idno type="doi">10.1093/intimm/11.7.1043</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-C04LKV2Q-6/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000950</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000950</idno><idno type="wicri:Area/Istex/Curation">000950</idno><idno type="wicri:Area/Istex/Checkpoint">000824</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000824</idno><idno type="wicri:doubleKey">0953-8178:1999:Ben Yedidia T:intranasal:administration:of</idno><idno type="wicri:Area/Main/Merge">001A71</idno><idno type="wicri:Area/Main/Curation">001A24</idno><idno type="wicri:Area/Main/Exploration">001A24</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection</title><author><name sortKey="Ben Yedidia, Tamar" sort="Ben Yedidia, Tamar" uniqKey="Ben Yedidia T" first="Tamar" last="Ben-Yedidia">Tamar Ben-Yedidia</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Immunology, The Weizmann Institute of Science, Rehovot 76100</wicri:regionArea><wicri:noRegion>Rehovot 76100</wicri:noRegion></affiliation></author><author><name sortKey="Marcus, Hadar" sort="Marcus, Hadar" uniqKey="Marcus H" first="Hadar" last="Marcus">Hadar Marcus</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Immunology, The Weizmann Institute of Science, Rehovot 76100</wicri:regionArea><wicri:noRegion>Rehovot 76100</wicri:noRegion></affiliation></author><author><name sortKey="Reisner, Yair" sort="Reisner, Yair" uniqKey="Reisner Y" first="Yair" last="Reisner">Yair Reisner</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Immunology, The Weizmann Institute of Science, Rehovot 76100</wicri:regionArea><wicri:noRegion>Rehovot 76100</wicri:noRegion></affiliation></author><author><name sortKey="Arnon, Ruth" sort="Arnon, Ruth" uniqKey="Arnon R" first="Ruth" last="Arnon">Ruth Arnon</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Immunology, The Weizmann Institute of Science, Rehovot 76100</wicri:regionArea><wicri:noRegion>Rehovot 76100</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Immunology</title><title level="j" type="abbrev">Int. Immunol.</title><idno type="ISSN">0953-8178</idno><idno type="eISSN">1460-2377</idno><imprint><publisher>Oxford University Press</publisher><date when="1999-07">1999</date><biblScope unit="vol">11</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="1043">1043</biblScope><biblScope unit="page" to="1051">1051</biblScope></imprint><idno type="ISSN">0953-8178</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0953-8178</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Influenza virus is characterized by frequent and unpredictable changes of the surface glycoproteins which enable the virus to escape the immune system. Approved vaccines which consist of the whole virus or the surface glycoproteins fail to induce broad specificity protection. We have previously reported that a peptide-based experimental recombinant vaccine which includes conserved epitopes of B and T lymphocytes was efficient in mice, leading to cross-strain, long-term protection. In the present study, this approach was adapted for the design of a human vaccine, based on epitopes recognized by the prevalent HLAs. These epitopes were expressed in Salmonella flagellin and tested for their efficacy in human/mouse radiation chimera in which human peripheral blood mononuclear cells (PBMC) are functionally engrafted. The vaccinated mice demonstrated clearance of the virus after challenge and resistance to lethal infection. The production of virus-specific human antibodies was also higher in this group. Control groups of either non-vaccinated, or vaccinated mice which had not been engrafted with the human PBMC, did not exhibit the protective immune response. FACS analysis showed that most human cells in the transplanted mice are CD8+ and CD4+. Hence, it may be concluded: (i) that the protection involves cellular mechanisms, but is most probably accomplished without direct lysis of influenza-infected pulmonary cells by cytotoxic T lymphocytes, but rather via a cytokine-mediated mechanism, (ii) that the human/mouse radiation chimera model may be of some value in the investigation of new vaccines, as an additional tool prior to clinical trials, and (iii) that the synthetic recombinant vaccine can induce a response in the human immune system and confers protection against influenza infection. Further investigation is needed to establish the efficacy of such a peptide vaccine in human subjects.</div></front></TEI><affiliations><list><country><li>Israël</li></country></list><tree><country name="Israël"><noRegion><name sortKey="Ben Yedidia, Tamar" sort="Ben Yedidia, Tamar" uniqKey="Ben Yedidia T" first="Tamar" last="Ben-Yedidia">Tamar Ben-Yedidia</name></noRegion><name sortKey="Arnon, Ruth" sort="Arnon, Ruth" uniqKey="Arnon R" first="Ruth" last="Arnon">Ruth Arnon</name><name sortKey="Marcus, Hadar" sort="Marcus, Hadar" uniqKey="Marcus H" first="Hadar" last="Marcus">Hadar Marcus</name><name sortKey="Reisner, Yair" sort="Reisner, Yair" uniqKey="Reisner Y" first="Yair" last="Reisner">Yair Reisner</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:61B2B4253296591CDF5453B79ABFB1264A5E5939
|texte= Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
}}
| This area was generated with Dilib version V0.6.33. |  |